Sen. James M. Inhofe sold Perrigo Company (PRGO)
Sen. James M. Inhofe (R-OK) · $50K–$100K · traded Aug 12, 2016
- Transaction
- Sold (full)
- Amount
- $50K–$100K
- Owner
- The member
- Traded
- Aug 12, 2016
- Disclosed
- Sep 12, 2016
- Days to disclose
- 31
- Asset type
- Stock
- As filed
- Perrigo Company plc
- Industry
- Drug Manufacturers - Specialty & Generic · Healthcare
Other trades in this filing
- Sep 12, 2016$15K–$50K
$15K–$50K · Traded Sep 15, 2016 · disclosed Sep 12, 2016
Recent Congress trades in PRGO
- Jun 22, 2023$50K–$100K
Rep. Michael T. McCaul (R-TX-10)
$50K–$100K · Traded May 18, 2023 · disclosed Jun 22, 2023 · Spouse
- Jun 22, 2023$15K–$50K
Rep. Michael T. McCaul (R-TX-10)
$15K–$50K · Traded May 18, 2023 · disclosed Jun 22, 2023
- Jun 22, 2023$50K–$100K
Rep. Michael T. McCaul (R-TX-10)
$50K–$100K · Traded May 17, 2023 · disclosed Jun 22, 2023 · Spouse
- Jun 22, 2023$15K–$50K
Rep. Michael T. McCaul (R-TX-10)
$15K–$50K · Traded May 17, 2023 · disclosed Jun 22, 2023
- Jun 22, 2023$15K–$50K
Rep. Michael T. McCaul (R-TX-10)
$15K–$50K · Traded May 12, 2023 · disclosed Jun 22, 2023
- Jun 22, 2023$100K–$250K
Rep. Michael T. McCaul (R-TX-10)
$100K–$250K · Traded May 12, 2023 · disclosed Jun 22, 2023 · Spouse
- Jan 10, 2017$15K–$50K
Sen. Susan M. Collins (R-ME)
$15K–$50K · Traded Dec 30, 2016 · disclosed Jan 10, 2017 · Spouse
- Jun 7, 2016$50K–$100K
Sen. James M. Inhofe (R-OK)
$50K–$100K · Traded May 23, 2016 · disclosed Jun 7, 2016
Company context for PRGO
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
PRGO: third_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Oct 19, 2026, 5:33 PM EDTOriginal source ↗PRGO: third_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Oct 16, 2026, 11:06 AM EDTOriginal source ↗PRGO: second_quarter 2026 lobbying report
Federal policy matters related to the manufacturing of infant formula and other public health issues. Federal policy matters related to the manufacturing of infant formula and other public health issues.
Public: Jul 20, 2026, 3:56 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.